NEW YORK (GenomeWeb) – Abbott reported on Thursday morning that its fourth quarter diagnostic revenues fell 1 percent year over year while its molecular diagnostics sales dropped 4 percent, both due to unfavorable currency effects.

The Abbott Park, Illinois-based company reported total worldwide revenues of $5.19 billion for the three months ended Dec. 31, down 3 percent from $5.36 billion a year ago and short of the Wall Street estimate of $5.23 billion. On an adjusted basis, excluding an 8 percent foreign currency headwind, Q3 sales increased 5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.